Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
HK |
|
Banco do Brasil SA
F:BZLA
|
BR |
|
B
|
Bactiquant A/S
CSE:BACTIQ
|
DK |
|
Antin Infrastructure Partners SAS
PAR:ANTIN
|
FR |
|
F
|
Fonix Mobile PLC
F:FOS
|
UK |
Wall Street
Price Targets
Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 11.22 HKD with a low forecast of 11.11 HKD and a high forecast of 11.55 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's stock price target?
Price Target
11.22
HKD
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 11.22 HKD with a low forecast of 11.11 HKD and a high forecast of 11.55 HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Revenue forecast?
Projected CAGR
20%
For the last 13 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's revenue is 12%. The projected CAGR for the next 2 years is 20%.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Operating Income forecast?
Projected CAGR
37%
For the last 13 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's operating income is 12%. The projected CAGR for the next 2 years is 37%.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income forecast?
Projected CAGR
33%
For the last 13 years the compound annual growth rate for Beijing Tong Ren Tang Chinese Medicine Co Ltd's net income is 7%. The projected CAGR for the next 2 years is 33%.
